The total number of outstanding shares recently increased from 1.09 billion to 1.51 billion. I believe is authorized for even more. That is an outrageous number of shares for a small biotech company. That amount will hold down the price appreciation as someone will be willing to sell at almost any price. If it makes $3-5/share be happy. That would make it a $4-6 billion market cap.